EQR
42
-2
AXP
66
-4
AVY
47
-3
EIX
45
-8
WM
50
-4
EQT
57
-7
QRVO
53
-2
CA
24
3
GILD
47
-9
CNP
55
-2
BRK.B
40
-3
TXN
53
-15
FLR
42
-3
LMT
57
7
NSC
60
-2
APD
34
-18
MMM
57
-4
TSN
43
-3
OI
49
-2
UHS
62
-2
EQR
42
-2
AXP
66
-4
AVY
47
-3
EIX
45
-8
WM
50
-4
EQT
57
-7
QRVO
53
-2
CA
24
3
GILD
47
-9
CNP
55
-2
BRK.B
40
-3
TXN
53
-15
FLR
42
-3
LMT
57
7
NSC
60
-2
APD
34
-18
MMM
57
-4
TSN
43
-3
OI
49
-2
UHS
62
-2
Financhill
Back

ProShares Ultra MSCI Emg Mkts Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
69

EET
ProShares Ultra MSCI Emg Mkts

Last Price:
$79.01
Seasonality Move:
3.97%
Buy
90

KYMR
Kymera Therapeutics, Inc.

Last Price:
$94.38
Seasonality Move:
7.7%
Buy
69
ProShares Ultra MSCI Emg Mkts (EET) is a Buy

Is ProShares Ultra MSCI Emg Mkts a Buy, Sell or Hold?

  • The current ProShares Ultra MSCI Emg Mkts [EET] share price is $78.83. The Score for EET is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • EET is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
90
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

EET Stock Price Chart

What is ProShares Ultra MSCI Emg Mkts's stock price today?

  • The ProShares Ultra MSCI Emg Mkts share price today is $78.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EET is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $94.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

EET Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 52 Buy
Chaikin Money Flow: -16536 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.75 - 80.85) Buy
Bollinger Bands (100): (68.51 - 79.85) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 86.88 Buy
Chaikin Money Flow: -462379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.8 - 71.72) Buy
Bollinger Bands (100): (43.38 - 63.26) Buy

EET Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 78.31 Buy
20-day SMA: 78.42 Buy
50-day SMA: 78.9 Sell
200-day SMA: 65.49 Buy
8-day EMA: 78.31 Buy
20-day EMA: 78.38 Buy
50-day EMA: 77.59 Buy
200-day EMA: 68.5 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70 Buy
20-day SMA: 66.61 Buy
50-day SMA: 61.97 Buy
200-day SMA: 44.25 Buy
8-day EMA: 72.36 Buy
20-day EMA: 67.57 Buy
50-day EMA: 61.93 Buy
200-day EMA: 49.42 Buy

ProShares Ultra MSCI Emg Mkts Earnings Growth & EET Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

ProShares Ultra MSCI Emg Mkts Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):